These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1413442)

  • 1. Clinical trial of long-acting oxytetracycline and piroxicam in the treatment of canine ehrlichiosis.
    Adawa DA; Hassan AZ; Abdullah SU; Ogunkoya AB; Adeyanju JB; Okoro JE
    Vet Q; 1992; 14(3):118-20. PubMed ID: 1413442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and clinical trials of long acting oxytetracycline in the treatment of canine ehrlichiosis.
    Ogunkoya AB; Adeyanju JB; Abduhllahi R
    Vet Q; 1985 Apr; 7(2):158-61. PubMed ID: 3892880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of a long-acting oxytetracycline formulation in healthy dogs and in dogs infected with Ehrlichia canis.
    Kikuvi GM; Mitema ES; Buoro IB
    Vet Res Commun; 2001 Jul; 25(5):391-400. PubMed ID: 11469510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytetracycline plasma levels in dogs after intramuscular administration of two formulations.
    Immelman A; Dreyer G
    J S Afr Vet Assoc; 1981 Sep; 52(3):191-3. PubMed ID: 7310789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of two different oxytetracycline treatments in experimental Ehrlichia phagocytophila infected lambs.
    Stuen S; Bergström K
    Acta Vet Scand; 2001; 42(3):339-46. PubMed ID: 11887394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs.
    Mutsaers AJ; Glickman NW; DeNicola DB; Widmer WR; Bonney PL; Hahn KA; Knapp DW
    J Am Vet Med Assoc; 2002 Jun; 220(12):1813-7. PubMed ID: 12092954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
    Elmslie RE; Glawe P; Dow SW
    J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors.
    Knapp DW; Richardson RC; Bottoms GD; Teclaw R; Chan TC
    Cancer Chemother Pharmacol; 1992; 29(3):214-8. PubMed ID: 1733554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
    Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
    J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
    Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
    J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the pathogenesis and treatment of canine monocytic ehrlichiosis (Ehrlichia canis).
    Harrus S
    Vet J; 2015 Jun; 204(3):239-40. PubMed ID: 25957922
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on the treatment of canine monocytic ehrlichiosis (Ehrlichia canis).
    Mylonakis ME; Harrus S; Breitschwerdt EB
    Vet J; 2019 Apr; 246():45-53. PubMed ID: 30902188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Dose Filgrastim Treatment of Nonregenerative Pancytopenia Associated With Chronic Canine Ehrlichiosis.
    Palacios M; Arteaga R; Calvo G
    Top Companion Anim Med; 2017 Mar; 32(1):28-30. PubMed ID: 28750787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study.
    Chon E; McCartan L; Kubicek LN; Vail DM
    Vet Comp Oncol; 2012 Sep; 10(3):184-93. PubMed ID: 22235941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs.
    Schmidt BR; Glickman NW; DeNicola DB; de Gortari AE; Knapp DW
    J Am Vet Med Assoc; 2001 Jun; 218(11):1783-6. PubMed ID: 11394830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for the efficacy of imidocarb dipropionate in the treatment of Ehrlichia canis infection.
    Matthewman LA; Kelly PJ; Brouqui P; Raoult D
    J S Afr Vet Assoc; 1994 Sep; 65(3):104-7. PubMed ID: 7595915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
    J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
    de Vos J; Ramos Vega S; Noorman E; de Vos P
    Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe.
    Sainz Á; Roura X; Miró G; Estrada-Peña A; Kohn B; Harrus S; Solano-Gallego L
    Parasit Vectors; 2015 Feb; 8():75. PubMed ID: 25649069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.
    de M Souza CH; Toledo-Piza E; Amorin R; Barboza A; Tobias KM
    Can Vet J; 2009 May; 50(5):506-10. PubMed ID: 19436636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.